The New York Mets have added two more arms to their bullpen mix, signing left-hander Anthony Gose and right-hander Luis Ortiz to minor league deals. Both contracts are worth $455,000 and include invitations to spring training. While Ortiz is unlikely to contribute in 2025 as he recovers from Tommy John surgery, Gose will look to carve out a role in the Mets’ relief corps.
Gose, a second-round pick by the Phillies in 2008, began his career as a highly touted outfielder before transitioning to pitching in 2016. He has since bounced around the league, spending time with the Tigers, Rangers, and Guardians. In 32 innings pitched for Cleveland, Gose posted a 4.78 ERA. After missing the entire 2023 season due to Tommy John surgery, Gose returned in 2024, allowing five earned runs on nine hits in 4 1⁄3 innings.
Ortiz, a first-round pick by the Rangers in 2014, has also experienced his fair share of ups and downs. He has been traded multiple times, suiting up for the Brewers, Orioles, Giants, and Phillies. Ortiz enjoyed his best season in 2022, posting a 1.04 ERA across 8 2⁄3 innings for San Francisco. However, he was limited to just 2⁄3 of an inning in 2024 due to injuries and eventually underwent Tommy John surgery.
The signings of Gose and Ortiz are consistent with the Mets’ offseason strategy, which has focused on adding low-risk, high-upside arms to the roster. General manager David Stearns has opted to avoid the more expensive end of the free agent market, instead targeting players who can provide value without breaking the bank.
The Mets’ bullpen, which has been a point of emphasis this offseason, now boasts a slew of potential options. Gose and Ortiz join a group that includes Dylan Covey, Génesis Cabrera, Rico Garcia, Chris Devenski, and Oliver Ortega, among others. Ortega, who owns a 4.03 ERA in 58 career innings, was also signed to a minor league deal earlier this offseason.
While the Mets’ bullpen is still a work in progress, the additions of Gose and Ortiz provide additional depth and flexibility. As the team prepares for spring training, these low-risk signings could ultimately pay dividends in the form of a stronger, more resilient bullpen.
